Drugs@FDA document

MIFEPREX Letter · NDA 020687 SUPPL-14

Drugs@FDA document · DANCO LABS LLC · Jun 9, 2011

Key facts

Drug name MIFEPREX
Document type Letter
Application NDA020687
Submission SUPPL-14
Company DANCO LABS LLC
Document date Jun 9, 2011
FDA document accessdata.fda.gov

At a glance

  • Labeling, REMS-Proposal Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents